Node Status
Learning Objectives
Describe Management of DR-TB ADR.
Sub Nodes
- Common or Relevant Adverse Effects of DR-TB Therapy
- Management of DR-TB ADR: Gastritis, abdominal pain
- Management of DR-TB ADR: Diarrhoea and/or Flatulence
- Management of DR-TB ADR: Giddiness
- Management of DR-TB ADR: Metallic Taste
- Management of DR-TB ADR: Hepatitis
- Management of DR-TB ADR: Hematological Abnormalities
- Management of DR-TB ADR: Hypothyroidism
- Management of DR-TB ADR: Arthralgia
- Management of DR-TB ADR: Depression
- Management of DR-TB ADR: Psychotic Symptoms
- Management of DR-TB ADR: Suicidal Ideation
- Management of DR-TB ADR: Seizures
- Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity]
- Management of DR-TB ADR: Gynecomastia
- Management of DR-TB ADR: Optic Neuritis
- Management of DR-TB ADR: QT Prolongation
- Management of ADR: Rash, Allergy and Anaphylaxis Reaction
- Management of DR-TB ADR: Peripheral Neuropathy
- Management of DR-TB ADR: Vestibular Toxicity
- Management of DR-TB ADR: Electrolyte Disturbances
- Management of DR-TB ADR: Alopecia
- Management of DR-TB ADR: Superficial Fungal Infection and Thrush
- Management of DR-TB ADR: Lactic Acidosis
- Management of DR-TB ADR: Dysglycaemia and Hyperglycemia
- Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
- Adverse Drug Events: H Mono/Poly DR-TB Regimen
- Management of Hepato-toxicity During Treatment with Shorter/Longer Oral MDR-TB Regimen
- Management of QT Prolongation by Grade of Severity of ADR
- Management of Prolonged QTcF During Treatment with Shorter/Longer Oral MDR-TB Regimen